ACQUISITION OF ALIP TECHNOLOGY (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Jun. 21, 2024 |
Jun. 30, 2025 |
Jun. 30, 2025 |
|
| Asset Acquisition [Line Items] | |||
| Contingent consideration | $ 836,500 | $ 1,774,500 | $ 1,774,500 |
| Revaluation expense | $ 401,500 | $ 1,004,000 | |
| ALIP Technology [Member] | |||
| Asset Acquisition [Line Items] | |||
| Number of shares issued for acquisitions | 50,000 | ||
| Cash consideration | $ 50,000 | ||
| ALIP Technology [Member] | Dr Maidana [Member] | |||
| Asset Acquisition [Line Items] | |||
| Number of shares issued for acquisitions | 50,000 | ||
| Cash consideration | $ 50,000 |
| X | ||||||||||
- Definition Revaluation expense. No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|